The impact of telemonitoring on correct drug use, complications and quality of life among patients with multiple myeloma (ITUMM): A study protocol for an open-label, parallel-group, randomized controlled trial.

Autor: Eijsink JFH; Department of Clinical Pharmacy, Isala, Zwolle, The Netherlands.; Department of Health Sciences, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Geerts PAF; Department of Internal Medicine, Isala, Zwolle, The Netherlands., Kamminga K; Department of Internal Medicine, Isala, Zwolle, The Netherlands., Edens MA; Department of Innovation and Science, Isala, Zwolle, The Netherlands., Boersma C; Department of Health Sciences, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Department of Management Sciences, Open University, Heerlen, The Netherlands., Postma MJ; Department of Management Sciences, Open University, Heerlen, The Netherlands.; Department of Economics, Econometrics & Finance, Faculty of Economics, University of Groningen, Groningen, The Netherlands., Maring JG; Department of Clinical Pharmacy, Isala, Zwolle, The Netherlands., Ter Horst PGJ; Department of Clinical Pharmacy, Isala, Zwolle, The Netherlands.

Publikováno v: PloS one [PLoS One] 2024 Aug 26; Vol. 19 (8), pp. e0307177. Date of Electronic Publication: 2024 Aug 26 (Print Publication: 2024).

Comparison of the CollaboRATE and SDM-Q-9 questionnaires to appreciate the patient-reported level of shared decision-making.

Autor: Ubbink DT; Amsterdam UMC location University of Amsterdam, Surgery, Amsterdam, The Netherlands. Electronic address: d.ubbink@amsterdamumc.nl., van Asbeck EV; Department of Obstetrics and Gynaecology, Radboud University Medical Center, Nijmegen, The Netherlands., Aarts JWM; Amsterdam UMC location University of Amsterdam, Obstetrics and Gynaecology, Amsterdam, The Netherlands., Stubenrouch FE; Department of Radiology, Onze Lieve Vrouwe Gasthuis, Location East, Amsterdam, The Netherlands., Geerts PAF; Department of Internal Medicine, Division of Haematology and School GROW, Maastricht University Medical Center, Maastricht, The Netherlands; Department of Internal Medicine, Division of Oncology, Isala Klinieken, Zwolle, The Netherlands., Atsma F; Radboud Institute for Health Sciences, Scientific Center for Quality of Healthcare, Radboud University Medical Center, Nijmegen, The Netherlands., Meinders MJ; Radboud Institute for Health Sciences, Scientific Center for Quality of Healthcare, Radboud University Medical Center, Nijmegen, The Netherlands.

Publikováno v: Patient education and counseling [Patient Educ Couns] 2022 Jul; Vol. 105 (7), pp. 2475-2479. Date of Electronic Publication: 2022 Mar 10.

Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study.

Autor: Stege CAM; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., Nasserinejad K; HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., van der Spek E; Department of Internal Medicine, Rijnstate Hospital, Arnhem, the Netherlands., Bilgin YM; Department of Internal Medicine, Admiraal de Ruijter Hospital, Goes, the Netherlands., Kentos A; Department of Hematology, Centre Hospitalier Jolimont, Haine-Saint-Paul, Belgium., Sohne M; Department of Internal Medicine/Hematology, St Antonius Hospital, Nieuwegein, the Netherlands., van Kampen RJW; Department of Internal Medicine, Zuyderland Medical Center, Sittard-Geleen, the Netherlands., Ludwig I; Department of Hematology, Bernhoven Hospital, Uden, the Netherlands., Thielen N; Department of Internal Medicine, Diakonessenhuis, Utrecht, the Netherlands., Durdu-Rayman N; Department of Internal Medicine-Hematology, Franciscus Hospital location Vlietland, Schiedam, the Netherlands., de Graauw NCHP; Department of Internal Medicine, Bravis Hospital, Roosendaal, the Netherlands., van de Donk NWCJ; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., de Waal EGM; Department of Internal Medicine, Medisch Centrum Leeuwarden, Leeuwarden, the Netherlands., Vekemans MC; Department of Hematology, St Luc Hospital, Bruxelles, Belgium., Timmers GJ; Department of Internal Medicine, Amstelland Hospital, Amstelveen, the Netherlands., van der Klift M; Department of Internal Medicine, Amphia Hospital, Breda, the Netherlands., Soechit S; Department of Hematology, Reinier de Graaf Groep, Delft, the Netherlands., Geerts PAF; Department of Internal Medicine, Deventer Hospital, Deventer, the Netherlands; Currently Isala, Zwolle, the Netherlands., Silbermann MH; Department of Internal Medicine, Tergooi Hospital, Hilversum, the Netherlands., Oosterveld M; Department of Internal Medicine, Canisius-Wilhelmina Hospital, Nijmegen, the Netherlands., Nijhof IS; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., Sonneveld P; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Klein SK; Department of Internal Medicine, Meander Medical Center, Amersfoort, the Netherlands., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands., Zweegman S; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Sep 01; Vol. 39 (25), pp. 2758-2767. Date of Electronic Publication: 2021 May 04.

The Next Step Toward Patient-Centeredness in Multidisciplinary Cancer Team Meetings: An Interview Study with Professionals.

Autor: Geerts PAF; Department of Internal Medicine, Division of Hematology and School GROW, Maastricht University Medical Centre, Maastricht, the Netherlands., van der Weijden T; Department of Family Medicine, Maastricht University, School CAPHRI, Maastricht, the Netherlands., Savelberg W; Oncology Centre, Maastricht University Medical Centre, Maastricht, the Netherlands., Altan M; Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, Maastricht, the Netherlands., Chisari G; Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, Maastricht, the Netherlands., Launert DR; Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, Maastricht, the Netherlands., Mesters H; Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, Maastricht, the Netherlands., Pisters Y; Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, Maastricht, the Netherlands., van Heumen M; Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, Maastricht, the Netherlands., Hermanns R; Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, Maastricht, the Netherlands., Bos GMJ; Department of Internal Medicine, Division of Hematology and School GROW, Maastricht University Medical Centre, Maastricht, the Netherlands., Moser A; Department of Family Medicine, Maastricht University, School CAPHRI, Maastricht, the Netherlands.; Zuyd University of Applied Sciences, Heerlen, the Netherlands.

Publikováno v: Journal of multidisciplinary healthcare [J Multidiscip Healthc] 2021 Jun 04; Vol. 14, pp. 1311-1324. Date of Electronic Publication: 2021 Jun 04 (Print Publication: 2021).

Developing a patient portal for haematology patients requires involvement of all stakeholders and a customised design, tailored to the individual needs.

Autor: Geerts PAF; Department of Internal Medicine, Division of Haematology, School GROW, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX, Maastricht, The Netherlands. paul.geerts@mumc.nl., van der Weijden T; Department of Family Medicine, Maastricht University, School CAPHRI, Maastricht, The Netherlands., Loeffen PGM; Faculty of Health and Medicine, Maastricht University, Maastricht, The Netherlands., Janssen LEF; Faculty of Health and Medicine, Maastricht University, Maastricht, The Netherlands., Almekinders C; Faculty of Health and Medicine, Maastricht University, Maastricht, The Netherlands., Wienhold TA; Faculty of Health and Medicine, Maastricht University, Maastricht, The Netherlands., Bos GMJ; Department of Internal Medicine, Division of Haematology, School GROW, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX, Maastricht, The Netherlands.

Publikováno v: BMC medical informatics and decision making [BMC Med Inform Decis Mak] 2019 Jul 11; Vol. 19 (1), pp. 129. Date of Electronic Publication: 2019 Jul 11.